P. A. Talaviya, B. M. Vyas, S. P. Indoria, and V. B. Modh, “Review on special emphasis of bortezomib on relapsed/refractory myeloma”, Int J Res Med Sci, vol. 2, no. 4, pp. 1278–1282, Jan. 2017.